Related Experiment Video
Updated: Jul 31, 2025
09:43
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Published on: October 14, 2019
6.6K
Small bowel neuroendocrine tumours - casting the net wide
Stefania Chetcuti Zammit1, Reena Sidhu2
1Gastroenterology Department, Mater Dei Hospital, Msida, Malta.
Current Opinion in Gastroenterology
|May 5, 2023
Summary
Small bowel neuroendocrine tumors (NETs) are heterogeneous, often presenting with diarrhea and weight loss. Early detection via DOTATATE scans and endoscopy, followed by surgical resection and targeted therapies, improves patient outcomes.
Area of Science:
- Gastroenterology
- Oncology
- Nuclear Medicine
Background:
- Small bowel neuroendocrine tumors (NETs) are rare, heterogeneous neoplasms.
- Clinical presentation often includes diarrhea and weight loss due to secretory behavior.
- Distal small bowel is the most common site, with liver metastases leading to carcinoid syndrome.
Approach:
- Overview of clinical presentation, diagnosis, and management of small bowel NETs.
- Review of latest evidence and future research directions.
- Comparative analysis of diagnostic imaging modalities.
Key Points:
- DOTATATE scan offers improved sensitivity for NET detection compared to Octreotide scan.
- Small bowel endoscopy is crucial for visualizing mucosal lesions.
- Surgical resection is the primary treatment, even for metastatic disease.
- Somatostatin analogues and Everolimus are effective second-line therapies.
Conclusions:
- Integrated diagnostic approach combining imaging and endoscopy is essential.
- Multidisciplinary management optimizing surgical and medical therapies improves prognosis.
- Further research is needed to refine treatment strategies for small bowel NETs.
